Dopamine, a co-regulatory component, bridges the central nervous system and the immune system
- PMID: 34847478
- DOI: 10.1016/j.biopha.2021.112458
Dopamine, a co-regulatory component, bridges the central nervous system and the immune system
Abstract
Dopamine (DA) is a crucial neurotransmitter that plays an important role in maintaining physiological function in human body. In the past, most studies focused on the relationship between the dopaminergic system and neurological-related diseases. However, it has been found recently that DA is an immunomodulatory mediator and many immune cells express dopamine receptors (DRs). Some immune cells can synthesize and secrete DA and then participate in regulating immune function. DRs agonists or antagonists can improve the dysfunction of immune system through classical G protein signaling pathways or other non-receptor-dependent pathways. This article will discuss the relationship between the dopaminergic system and the immune system. It will also review the use of DRs agonists or antagonists to treat chronic and acute inflammatory diseases and corresponding immunomodulatory mechanisms.
Keywords: Agonist; Antagonist; Dopamine receptor; Immune system; Inflammation.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Similar articles
-
Dopamine receptors--physiological understanding to therapeutic intervention potential.Pharmacol Ther. 1999 Nov;84(2):133-56. doi: 10.1016/s0163-7258(99)00029-7. Pharmacol Ther. 1999. PMID: 10596903 Review.
-
The immunoregulatory role of dopamine: an update.Brain Behav Immun. 2010 May;24(4):525-8. doi: 10.1016/j.bbi.2009.10.015. Epub 2009 Nov 5. Brain Behav Immun. 2010. PMID: 19896530 Free PMC article. Review.
-
Dopamine, a neurotransmitter, influences the immune system.J Neuroimmunol. 2000 Jan 24;102(2):113-24. doi: 10.1016/s0165-5728(99)00176-9. J Neuroimmunol. 2000. PMID: 10636479 Review.
-
Aripiprazole, a novel antipsychotic agent: dopamine D2 receptor partial agonist.J Med Invest. 2005 Nov;52 Suppl:284-90. doi: 10.2152/jmi.52.284. J Med Invest. 2005. PMID: 16366516 Review.
-
Dopamine receptor agonist- and antagonist-induced behaviors in primates previously treated with dopamine receptor antagonists: the pathogenetic mechanisms of acute oral dyskinesia.Clin Neuropharmacol. 1995 Dec;18(6):533-51. doi: 10.1097/00002826-199512000-00005. Clin Neuropharmacol. 1995. PMID: 8681313
Cited by
-
Continuous Activation of Dopamine Receptors Alleviates LPS-Induced Liver Injury in Mice via β-arrestin2 Dependent Akt/NF-κB Pathway.Front Pharmacol. 2022 Mar 14;13:853834. doi: 10.3389/fphar.2022.853834. eCollection 2022. Front Pharmacol. 2022. PMID: 35359858 Free PMC article.
-
Neurotoxicology of dopamine: Victim or assailant?Neurotoxicology. 2024 Jul;103:175-188. doi: 10.1016/j.neuro.2024.06.001. Epub 2024 Jun 8. Neurotoxicology. 2024. PMID: 38857676 Free PMC article. Review.
-
Spongin as a Unique 3D Template for the Development of Functional Iron-Based Composites Using Biomimetic Approach In Vitro.Mar Drugs. 2023 Aug 22;21(9):460. doi: 10.3390/md21090460. Mar Drugs. 2023. PMID: 37755073 Free PMC article.
-
Characterization of Freshly Isolated Human Peripheral Blood B Cells, Monocytes, CD4+ and CD8+ T Cells, and Skin Mast Cells by Quantitative Transcriptomics.Int J Mol Sci. 2024 Dec 4;25(23):13050. doi: 10.3390/ijms252313050. Int J Mol Sci. 2024. PMID: 39684762 Free PMC article.
-
Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881. Int J Mol Sci. 2025. PMID: 40725128 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous